Clinically isolated syndrome (CIS) is a single episode of neurological symptoms caused by inflammation and damage to the protective coating around nerves in the brain or spinal cord. The episode must last at least 24 hours, and it often looks and feels a lot like a first attack of multiple sclerosis. In fact, CIS is considered a possible precursor to MS, though not everyone who experiences it will go on to develop the disease. Whether CIS remains a one-time event or becomes something more depends largely on what doctors find on brain imaging and spinal fluid tests.
What Happens During a CIS Episode
CIS occurs when the immune system mistakenly attacks myelin, the insulating layer around nerve fibers in the central nervous system. This disrupts normal nerve signaling, and the symptoms you experience depend on where the damage occurs. The attack can affect one area of the nervous system (monofocal) or several areas at once (multifocal), and it typically targets the optic nerve, brainstem, cerebellum, spinal cord, or cerebral hemispheres.
To qualify as CIS rather than something else, the episode must last at least 24 hours and can’t be explained by fever, infection, or a broader brain condition like encephalitis. It’s a single event, by definition. If a second episode happens later, the diagnosis usually shifts to multiple sclerosis.
Most Common Symptoms
The most frequent presentation is optic neuritis, which accounts for roughly 48% of CIS cases. It causes blurry or lost vision in one eye, often with pain behind the eye that worsens with movement. The second most common is incomplete transverse myelitis, affecting the spinal cord in about 28% of cases. This can cause weakness in the legs, numbness or tingling, and an electric shock sensation running down the spine when you bend your neck (known as Lhermitte sign).
Other symptoms depend on where the inflammation strikes. Brainstem involvement can cause double vision, slurred speech, or difficulty coordinating eye movements. Sensory symptoms like numbness or tingling in the limbs appear in about 36% of people. Less commonly, CIS can cause weakness on one side of the body or, rarely, seizures.
How CIS Is Diagnosed
The diagnostic workup starts with a brain MRI. Doctors are looking for bright spots on the scan called white matter lesions, which indicate areas where myelin has been damaged. Depending on your symptoms, you may also get an MRI of the optic nerves or the spinal cord. Between 50% and 70% of people with CIS already have multiple silent lesions on their first brain MRI, meaning the inflammation has been more widespread than their symptoms suggest.
A spinal tap (lumbar puncture) checks the cerebrospinal fluid for oligoclonal bands, which are markers of immune activity inside the nervous system. In one prospective study, the presence of these bands had a sensitivity of 80% and specificity of nearly 86% for predicting who would later develop MS, making it one of the strongest early indicators. The test also helps rule out infections and other conditions. If the fluid shows very high white blood cell counts or elevated protein levels, doctors start considering alternative diagnoses.
Evoked potential tests measure how quickly electrical signals travel along your nerves. Visual evoked potentials are abnormal in about 30% of people with CIS even when they have no vision complaints, which tells doctors that demyelination may be happening in places the patient can’t feel yet. Sensory and auditory evoked potentials can pick up similar hidden damage along other nerve pathways.
Blood tests are also part of the process, not to confirm CIS itself but to exclude conditions that can mimic it: infections, other autoimmune diseases, vitamin deficiencies, and vascular problems.
Conditions That Look Like CIS
Two conditions in particular can closely resemble CIS and need to be ruled out: MOG antibody disease (MOGAD) and neuromyelitis optica spectrum disorder (NMOSD). Both involve attacks on the central nervous system but follow different patterns and require different treatments.
MOGAD tends to cause optic neuritis in both eyes at once and affects the front portions of the optic nerve. On brain MRI, it often shows lesions near the surface of the brain. After an attack, the spinal cord typically recovers without lasting shrinkage. NMOSD, by contrast, tends to affect the back portions of the optic nerve and an area of the brainstem called the area postrema (which can cause severe nausea and vomiting). NMOSD is more likely to leave permanent spinal cord damage visible as atrophy on MRI. Blood tests for specific antibodies (MOG and aquaporin-4) help distinguish these conditions from CIS.
Risk of Developing Multiple Sclerosis
The single biggest factor in predicting whether CIS will convert to MS is what the first brain MRI shows. About 30% of people who have abnormal MRI findings at the time of their CIS episode will experience a second clinical attack or new MRI changes within one year, which is enough to confirm an MS diagnosis. The more lesions on that initial scan, the higher the risk climbs.
Oligoclonal bands in the spinal fluid push the odds further. In the study mentioned earlier, the predictive value of finding these immune markers was over 92% for eventual progression to MS in people with brainstem or spinal cord episodes. In the 2017 revision of the McDonald diagnostic criteria (the standard framework neurologists use), the presence of oligoclonal bands can now count as evidence of disease “dissemination in time,” meaning it can help establish an MS diagnosis even after a single clinical event if MRI findings also meet certain thresholds.
On the other end of the spectrum, people who have a normal brain MRI and no oligoclonal bands at the time of CIS have a much lower risk. Many of them never experience a second episode.
Treatment After a CIS Diagnosis
The acute episode itself is typically treated with a short course of high-dose corticosteroids to reduce inflammation and speed recovery. This doesn’t change the long-term outlook, but it can shorten the duration of symptoms.
The bigger question is whether to start disease-modifying therapy to prevent a second attack. Current NHS guidelines list several treatment options for people who’ve had a single clinical episode with signs of ongoing radiological activity on MRI. These include injectable therapies and newer oral or infusion-based medications. When imaging or other markers suggest a high risk of rapid disability, more potent therapies may be considered even at this early stage, though this decision involves weighing potential side effects against uncertain benefit.
There’s an important caveat. Trials of first-line therapies in people originally classified as having CIS at high risk of conversion have not shown a convincing long-term effect on the accumulation of disability. The UK’s National Institute for Health and Care Excellence (NICE) has acknowledged that evolving diagnostic criteria have made it difficult to draw firm conclusions from older CIS treatment studies. In practice, the decision to start treatment is highly individual and depends on how many risk factors are present.
What Recovery Looks Like
Most people recover partially or fully from a CIS episode, though the timeline varies by the type and severity of symptoms. Optic neuritis often improves substantially over weeks, with many people regaining most of their vision, though subtle changes in color perception or contrast sensitivity can linger. Spinal cord symptoms like weakness or numbness may take longer to resolve and are more likely to leave some residual effects.
After recovery, the focus shifts to monitoring. Regular MRI scans, typically every 6 to 12 months in the early period, track whether new silent lesions are forming. New lesions, even without new symptoms, can change the diagnosis from CIS to MS and influence treatment decisions. For people whose scans remain stable and who don’t experience new symptoms, the intervals between monitoring visits gradually lengthen.